Enovix (ENVX) EBT (2020 - 2026)

Enovix has reported EBT for 7 years, with the latest figure at -$38.4 million in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 62.02% year-over-year to -$38.4 million; the trailing twelve-month figure through Apr 2026 stood at -$172.6 million (up 14.11% YoY), and the FY2025 full-year result was -$157.9 million, up 29.48% from the prior year.
• EBT for Q2 2026 stood at -$38.4 million, down from -$34.9 million in the prior quarter.
• The five-year high for EBT was -$16.2 million in Q4 2023, with the low at -$120.5 million in Q2 2024.
• Historically, EBT has averaged -$47.5 million across 5 years, with a median of -$38.4 million in 2026.
• Annual changes were most pronounced in 2022 — EBT surged 76.81% — and 2023, when it tumbled 193.06%.
• Enovix's EBT stood at -$31.9 million in 2022, then plunged by 89.99% to -$60.7 million in 2023, then jumped by 40.17% to -$36.3 million in 2024, then rose by 3.83% to -$34.9 million in 2025, then decreased by 9.97% to -$38.4 million in 2026.
• The last three EBT figures came in at -$38.4 million (Q2 2026), -$34.9 million (Q4 2025), and -$54.2 million (Q3 2025), per Business Quant data.